# Samumed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/samumed

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.samumed.com
- Total disclosed funding: $438M
- Latest round: Series A (Aug 6, 2018)
- Investors on record: 2

## About

Founded in 2008 and based in California, US, Biosplice Therapeutics, Inc., formerly known as Samumed, LLC develops small molecule drugs for the treatment of cancer types and other degenerative diseases.

## Funding rounds

- Series A, Aug 6, 2018, $438M — Starling Group, Vickers Venture Partners

## Investors

- Starling Group — Series A
- Vickers Venture Partners (https://capitalatlas.ai/funds/vickers-venture-partners) — Series A